These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5916134)

  • 1. Measurement of antihemophilic factor activity in plasma.
    Penner JA
    J Lab Clin Med; 1966 Jun; 67(6):1025-35. PubMed ID: 5916134
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of a clinical trial of a Canadian preparation of antihemophilic factor.
    Magnin AA; Johnson SE
    Can Med Assoc J; 1979 Aug; 121(4):422-4, 427. PubMed ID: 466616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihemophilic cryoprecipitate from fresh plasma and its use in hemophilia A].
    Brüster H; Glassner K; Riech PC
    Dtsch Med Wochenschr; 1967 Oct; 92(41):1859-66. PubMed ID: 6057144
    [No Abstract]   [Full Text] [Related]  

  • 4. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudohemophilia due to antihemophilic globulin inhibitor (factor VIII)].
    Procházka J; Podivínský R; Kouril F; Hadam I; Velemínský J
    Vnitr Lek; 1970 Nov; 16(11):1091-103. PubMed ID: 5488288
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recognizing hemophilia in its latent form].
    Stakovetskaia ZS
    Vrach Delo; 1972 May; 5():105-7. PubMed ID: 5029774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ; Pool JG; Pappenhagen AR
    J Lab Clin Med; 1966 Jan; 67(1):23-32. PubMed ID: 5321736
    [No Abstract]   [Full Text] [Related]  

  • 9. Extensive surgical procedures in patients with hemophilia A.
    Rudowski WJ; Ziemski JM
    Surg Gynecol Obstet; 1972 Oct; 135(4):571-6. PubMed ID: 5077723
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and control of antihemophilic globulin (plasma factor 8).
    Zukoski CF; Hutchin P; Webster WP; Penick G
    Surg Forum; 1970; 21():370-1. PubMed ID: 4936991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Degree of severity of hemophilia. Relationship between blood coagulation tests and clinical findings].
    Weissbach G; Bührdel P
    Dtsch Gesundheitsw; 1971 Aug; 26(33):1570-5. PubMed ID: 5113164
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acquired coagulation diseases due to selective inactivation of factor VIII (2 cases of pseudohemophilia due to anticoagulants)].
    Sánchez-Fayos J; Outeiriño J; Jiménez Casado M; Paniagua G
    Rev Clin Esp; 1968 Jul; 110(1):15-20. PubMed ID: 5735072
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular complex of factor VIII (antihemophilic factor) in hepatopathies].
    Vicente V; Batlle J; López Borrasca A
    Rev Esp Enferm Apar Dig; 1979 Mar; 55(3):279-90. PubMed ID: 472427
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.
    LANGDELL RD; WAGNER RH; BRINKHOUS KM
    J Lab Clin Med; 1953 Apr; 41(4):637-47. PubMed ID: 13045017
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    Trans Assoc Am Physicians; 1980; 93():175-81. PubMed ID: 6787773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acquired hemophilia A as a cause of postoperative bleeding].
    Leimkühler K; Bach F; Kobert K; Korth M; Schmidt B; Kulbe C; Gummelt I; Mertzlufft F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 May; 38(5):359-65. PubMed ID: 12712401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rare disease but with a very high hemorrhagic risk: acquired hemophilia A].
    Delisle V; Ternisien C; Beurrier P; Zandecki M
    Ann Biol Clin (Paris); 2000; 58(6):741-4. PubMed ID: 11098173
    [No Abstract]   [Full Text] [Related]  

  • 19. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the lymphocyte in antihemophilic globulin production: a rise in antihemophilic globulin levels in a hemophilic subject with acute lymphoblastic leukemia.
    Bouhasin JD; Monteleone P; Altay C
    J Lab Clin Med; 1971 Jul; 78(1):122-9. PubMed ID: 5285069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.